
1. ebiomedicine. 2017 nov;25:58-65. doi: 10.1016/j.ebiom.2017.09.037. epub 2017 oct 
3.

evaluating causal link malaria infection endemic burkitt lymphoma
in northern uganda: mendelian randomization study.

legason id(1), pfeiffer rm(2), udquim ki(3), bergen aw(4), gouveia mh(5),
kirimunda s(6), otim i(1), karlins e(7), kerchan p(1), nabalende h(1),
bayanjargal a(8), emmanuel b(9), kagwa p(1), talisuna ao(10), bhatia k(11),
yeager m(12), biggar rj(4), ayers lw(13), reynolds sj(14), goedert jj(4), ogwang 
md(15), fraumeni jf jr(16), prokunina-olsson l(17), mbulaiteye sm(18).

author information: 
(1)emblem study, african field epidemiology network, p.o. box 12874, kampala,
uganda.
(2)division cancer epidemiology genetics, national cancer institute,
national institutes health, 9609 medical ctr dr, bethesda 20892, md, usa.
electronic address: pfeiffer@mail.nih.gov.
(3)laboratory translational genomics, division cancer epidemiology and
genetics, national cancer institute, national institutes health, bethesda, md,
usa. electronic address: krizia-ivana.udquim@nih.gov.
(4)division cancer epidemiology genetics, national cancer institute,
national institutes health, 9609 medical ctr dr, bethesda 20892, md, usa.
(5)instituto de pesquisa rene rachou, fundação oswaldo cruz, 30190-002 belo
horizonte, minas gerais, brazil.
(6)department medical microbiology, college health sciences, makerere
university, p.o. box 7072, kampala, uganda.
(7)division cancer epidemiology genetics, national cancer institute,
national institutes health, 9609 medical ctr dr, bethesda 20892, md, usa.
electronic address: karlinser@mail.nih.gov.
(8)laboratory translational genomics, division cancer epidemiology and
genetics, national cancer institute, national institutes health, bethesda, md,
usa.
(9)emblem study, african field epidemiology network, p.o. box 12874, kampala,
uganda; benjamin emmanuel, institute human virology, university maryland
school medicine, baltimore, md, usa. electronic address:
ben.emmanuel@umaryland.edu.
(10)world health organization, regional office africa, brazzaville, congo.
(11)division cancer epidemiology genetics, national cancer institute,
national institutes health, 9609 medical ctr dr, bethesda 20892, md, usa.
electronic address: kishor.bhatia@cgix.com.
(12)division cancer epidemiology genetics, national cancer institute,
national institutes health, 9609 medical ctr dr, bethesda 20892, md, usa.
electronic address: yeagerm@mail.nih.gov.
(13)department pathology, ohio state university, columbus, oh, usa.
electronic address: leona.ayers@osumc.edu.
(14)division intramural research, national institute allergy infectious
diseases, national institutes health, bethesda, md, usa. electronic address:
sreynol6@jhmi.edu.
(15)emblem study, st. mary's hospital, lacor, p.o. box 180, gulu, uganda.
electronic address: ogwang.martin@lacorhospital.org.
(16)division cancer epidemiology genetics, national cancer institute,
national institutes health, 9609 medical ctr dr, bethesda 20892, md, usa.
electronic address: fraumenj@exchange.nih.gov.
(17)laboratory translational genomics, division cancer epidemiology and
genetics, national cancer institute, national institutes health, bethesda, md,
usa. electronic address: prokuninal@mail.nih.gov.
(18)division cancer epidemiology genetics, national cancer institute,
national institutes health, 9609 medical ctr dr, bethesda 20892, md, usa.
electronic address: mbulaits@mail.nih.gov.

background: plasmodium falciparum (pf) malaria infection suspected cause
endemic burkitt lymphoma (ebl), evidence remains unsettled. inverse
relationship sickle cell trait (sct) ebl, supports between
malaria ebl, reported before, small studies low power.
we investigated hypothesis children population-based study in
northern uganda using mendelian randomization.
methods: malaria-related polymorphisms (sct, il10, il1a, cd36, sema3c, and
ifnar1) genotyped 202 ebl cases 624 controls enrolled during
2010-2015. modeled associations genotypes ebl malaria using
logistic regression.
findings: sct associated decreased risk ebl (adjusted odds ratio [or]
0·37, 95% ci 0·21-0·66; p=0·0003). decreased risk ebl associated il10
rs1800896-ct (or 0·73, 95% ci 0·50-1·07) -cc genotypes (or 0·53, 95% ci
0·29-0·95, ptrend=0·019); il1a rs2856838-ag (or 0·56, 95% ci 0·39-0·81) -aa
genotype (or 0·50, 95% ci 0·28-1·01, ptrend=0·0016); sema3c rs4461841-ct or
-cc genotypes (or 0·57, 95% ci 0·35-0·93, p=0·0193). sct il10 rs1800896, il1a
rs2856838, sema3c rs4461841, polymorphisms associated decreased
risk malaria controls.
interpretation: results support causal effect malaria infection ebl.

published elsevier b.v.

doi: 10.1016/j.ebiom.2017.09.037 
pmcid: pmc5704046
pmid: 29033373  [indexed medline]

